Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 18.6M | 11.7M | 21.3M | 20.1M |
Other operating expenses | — | — | — | — |
Operating income | -18.6M | -11.7M | -21.3M | -20.1M |
Non operating interest income | ||||
Income | 10.4M | 8.8M | 8.8M | 5.3M |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 23.4M | 28.6M | -79.9M | 111.6M |
Tax provision | 3.8M | 10.3M | -91.1M | 13.5M |
Net income | 19.6M | 18.2M | 11.3M | 98.1M |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.1 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.1 |
Basic average shares | 720.3M | 679.3M | 679.3M | 679.3M |
Diluted average shares | 720.3M | 679.3M | 679.3M | 679.3M |
EBITDA | -18.4M | -11.5M | -21.1M | -19.9M |
Net income from continuing op. | 23.4M | 28.6M | -79.9M | 111.6M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |